IRIS
VENEZIANI, BIANCA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.764
EU - Europa 1.448
AS - Asia 1.148
SA - Sud America 50
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.450
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.688
IT - Italia 592
SG - Singapore 578
CN - Cina 274
HK - Hong Kong 246
FI - Finlandia 128
FR - Francia 125
DE - Germania 123
RU - Federazione Russa 123
IE - Irlanda 111
NL - Olanda 108
CA - Canada 75
UA - Ucraina 75
BR - Brasile 44
CI - Costa d'Avorio 33
IN - India 24
GB - Regno Unito 23
SE - Svezia 19
VN - Vietnam 12
AT - Austria 4
AR - Argentina 3
BE - Belgio 3
PK - Pakistan 3
PL - Polonia 3
ZA - Sudafrica 3
EG - Egitto 2
ES - Italia 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
LT - Lituania 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
JO - Giordania 1
MK - Macedonia 1
MX - Messico 1
RS - Serbia 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 4.450
Salva come PNG Salva come JPEG
Città #
Singapore 320
Hong Kong 246
Chandler 209
Napoli 176
Jacksonville 117
Santa Clara 114
Princeton 112
Amsterdam 100
Millbury 96
Nanjing 93
Naples 91
Boston 82
Ashburn 80
Ottawa 68
Wilmington 62
Beijing 44
Nanchang 25
Des Moines 22
Falls Church 21
Hebei 21
Norwalk 20
Dublin 19
Woodbridge 19
Tianjin 18
Helsinki 17
Pune 16
Changsha 14
Hicksville 14
Shenyang 14
Dong Ket 12
Redwood City 12
Rome 11
Palma Campania 10
Formia 9
Jiaxing 9
Moscow 9
Ann Arbor 8
Boardman 8
Milan 8
San Mateo 8
Seattle 8
Afragola 7
Hangzhou 7
Nuremberg 7
Kunming 6
Los Angeles 6
New York 6
Redmond 6
Salerno 6
The Dalles 6
Florence 5
Indiana 5
Munich 5
Portici 5
Toronto 5
Caserta 4
Dallas 4
Falkenstein 4
Frankfurt am Main 4
Kolkata 4
Kronberg 4
Montecorvino Rovella 4
Shanghai 4
Angri 3
Brussels 3
Casoria 3
Giugliano In Campania 3
Leawood 3
London 3
Marano Di Napoli 3
Padova 3
São Paulo 3
Villaricca 3
Alpignano 2
Ardabil 2
Augusta 2
Belo Horizonte 2
Campinas 2
Changchun 2
Curitiba 2
Dearborn 2
Fremont 2
Goiânia 2
Lahore 2
Lanzhou 2
Lappeenranta 2
Manassas 2
Matera 2
Mauá 2
Newark 2
Orange 2
Pomigliano d'Arco 2
Sarno 2
Stockholm 2
Vienna 2
Villarosa 2
Volta Redonda 2
Warsaw 2
Washington 2
Zhengzhou 2
Totale 2.560
Salva come PNG Salva come JPEG
Nome #
Progetto dimostratore di analisi dei tessuti: BIONCAM BIObanca ONcologica CAMpania 212
Epigenetic silencing of THY1 tracks the acquisition of the Notch1-EGFR signaling in a xenograft model of CD44+/CD24low/CD90+ myoepithelial cells 104
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors 103
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 99
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers 75
1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells 66
Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells. 64
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status 63
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results 61
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. 58
Epidermal growth factor receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. 56
The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment 55
Reti dinamiche di apprendimento a distanza 54
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma. 54
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex 54
Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2B 54
Exploring the molecular aspects associated with testicular germ cell tumors: A review 54
ALTERATIONS OF AUTOPHAGIC FLUX IN CHARCOT-MARIE-TOOTH 2B DISEASE 53
Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 53
Tranfected Insulin- like growth factor II modulates the mitogenic response of rat thyrocytes in culture 52
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells 52
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. 52
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. 50
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 50
The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models. 50
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES. 48
A banking strategy toward customized therapy in breast cancer. 48
Long-term cultures of stem/progenitor cells from lobular and ductal breastcarcinomas under non-adherent conditions. 48
Circulating and disseminated tumor cells from breast cancer patient 48
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. 47
Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor. 47
P0081 Src inhibitors act through different mechanisms to cooperate with EGFR or MEK inhibitors in NSCLC models sensitive or resistant to erlotinib 47
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 46
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 46
Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs. 46
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity 45
AIRC Regional Grant ; “Breast cancer: preclinical and clinical development of therapeutic strategies targeting molecular mechanisms”. 45
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase 45
Iodine Inhibits the Proliferation of Rat-thyroid Cells In Culture 45
Adenosine 3',5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. 44
Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine. 41
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 40
SPHINGOSINE KINASE 1 (SPHK1) CONTRIBUTES TO RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS IN COLORECTAL CANCER MODELS 39
SRC INHIBITORS ACT THROUGH DIFFERENT MECHANISMS TO COOPERATE WITH EGFR OR MEK INHIBITORS IN NSCLC MODELS SENSITIVE OR RESISTANT TO ERLOTINIB 39
Micrornas in prostate cancer: an overview 39
Adenosine Has Divergent Effects On Deoxyribonucleic-acid Synthesis In Frtl5 Cells - Inhibition of Thyrotropin-stimulated and Potentiation of Insulin-like Growth Factor-i-stimulated Thymidine Incorporation 38
Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes 38
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 37
ADE-SOCRATES- Sperimentazione di e-learning su un corso di Attività Didattica Elettiva della Facoltà di Medicina e Chirurgia di Napoli “Federico II”. In: Reti dinamiche di apprendimento a distanza, U. Giani ed. Liguori Editore, pp. 345-350, 2004. ISBN: 88-207-3637-3 37
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity. 36
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 36
Annual Meeting of the ECTS Medical Association 36
Principi di Patologia Generale 35
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. 35
Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299). 34
Realizzazione e potenziamento di laboratori pubblici nei settori delle "scienze della nutrizione", "chirurgia avanzata" e "analisi dei tessuti". 32
INHIBITION OF CANCER CELL GROWTH AND INVASION BY TARGETING C-SRC IN BREAST CANCER MODELS RESISTANT TO ANTI-HER2 DRUGS 32
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review 32
In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches. 31
The disulfide bond pattern between fragments obtained by the limited proteolysis of bovine thyroglobulin. 31
Expression of genes related to cell cycle in thyroid cells in culture. 31
Independent and interactive effects of tetradecanoyl phorbol acetate on growth and differentiated functions of FRTL5 cells. 31
Endogenous IGF-II as a possible regulator of fetal rat thyroid gland development. 31
Sustained versus transient cyclic AMP intracellular levels: effect on thyrotropin-dependent growth of thyroid cells. 31
Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. 30
Endogenous IGFs modulates the mitogenic response of rat thyrocites in culture. 30
Inibizione della proliferazione: ruolo del cAMP. 30
Expression of the Soluble Lectin L-14 Gene Is Induced By Tsh In Thyroid-cells and Suppressed By Retinoic Acid In Transformed Neural Cells 30
Ruolo di fattori di crescita autocrini nel controllo della proliferazione di cellule di tiroide di ratto in coltura. 29
On the role of iodine on the proliferation of FRTL5 cells. 29
Evidence of a biological role of an endogenous growth factor on the proliferation of rat thyroid cells. 29
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 29
Condroitin-6-sulfate carbohydrate units. A major source of molecular microheterogeneity of human thyroglobulin. 28
Iodine inhibits the proliferation of rat thyroid cells in culture. 28
Growth control of follicular cells in vitro. 28
Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water 28
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review 27
Expression of the soluble lectin L-14 gene is induced by TSH in thyroid cells and suppressed by retinoic acid in transformed neural cells. 27
“Pharmacogenetics and endocrine therapy in postmenopausal early breast cancer patients. Correlation study of gene CYP19 and CYP2D6 polymorphisms with efficacy and toxicity” 27
The tissue-specific pathways regulating cell proliferation are inherited independently in somatic hybrid between thyroid and liver cells. 27
Elevated intracellular concentrations of cAMP act as a negative modulator of thyroid cell proliferation. 27
Studio GIM5: Studio di correlazione tra il gene CYP19 e l’efficacia di Letrozolo in pazienti in postmenopausa con tumore della mammella 27
IGF endogeno e proliferazione di tireociti. 27
Iodine inhibits the proliferation of rat thyroid cells in culture. 26
Pharmacogenetics and Endocrine therapy in postmenopausal early breast cancer patients. Correlation study of gene CYP19 and CYP2D6 polymorphisms with efficacy and Toxicity. 26
Dissociation and reassociation of non-covalently linked dimers of human 19S thyroglobulin treated with urea. 26
In the thyroid cells proliferation, differentiated and metabolic functions are under the control of different steps of the cyclic AMP cascade. 26
Adenosine has divergent effects on deoxyribonucleic acid synthesis in FRTL5 cells: inhibition of thyrotropin-stimulated and potentiation of insulin-like growth factor-I-stimulated thymidine incorporation. 26
Iodine inhibits thyroid cell proliferation through a cAMP-independent mechanism. 26
Oncotech 26
Independent and Interactive Effects of Tetradecanoyl Phorbol Acetate On Growth and Differentiated Functions of Frtl5 Cells 26
The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer 25
Iodine inhibits the proliferation of rat thyroid cells. 25
Endogenous IGFs modulate the mitogenic response in rat thyrocites in culture. 25
Molecular mechanisms in tumorigenesis of poorly differentiated thyroid carcinomas. 25
Effect of serum on the proliferation induced by TSH and IGF-I in FRTL5 cells. 25
Epithelial-mesenchymal transition in prostate cancer: an overview 25
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). 24
Transfected insulin-like growth factor II modulates the mitogenic response of rat thyrocytes in culture. 24
TSH-EGF cooperation in the FRTL5 thyroid cell growth stimulation. 24
Totale 4.202
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.356
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020169 0 0 0 0 0 0 0 0 0 21 57 91
2020/2021320 12 15 32 24 28 40 19 19 52 13 46 20
2021/2022701 11 0 6 12 28 23 22 29 117 55 116 282
2022/2023605 124 43 20 23 65 60 2 51 72 106 28 11
2023/2024475 17 58 72 38 32 56 4 41 1 5 101 50
2024/20251.378 154 167 9 52 58 128 332 136 263 79 0 0
Totale 4.596